FDA REQUESTS RECALL OF SHARPS CONTAINERS

被引：0

|

作者：

BURNETT, AA

机构：

来源：

LANCET | 1995年 / 346卷 / 8969期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：242 / 242

页数：1

相关论文

共 50 条

[31] The effects of lobbying on the FDA’s recall classification
Yifan Zhou
[J]. BMC Medical Ethics, 24
[32] The effects of lobbying on the FDA's recall classification
Zhou, Yifan
[J]. BMC MEDICAL ETHICS, 2023, 24 (01)
[33] Dietary supplements available despite FDA recall
[J]. Reactions Weekly, 2014, 1532 (1) : 11 - 11
[34] Health Canada requests recall of CHAMPIX lots due to impurity
[J]. Reactions Weekly, 2021, 1864 (1) : 3 - 3
[35] FDA requests boxed warnings on older class of antipsychotic drugs
不详
[J]. PSYCHIATRIC ANNALS, 2008, 38 (07) : 436 - 436
[36] IRRADIATED FOOD - FDA BLOCKS AEC ARMY REQUESTS FOR APPROVAL
JAMISON, A
[J]. SCIENCE, 1968, 161 (3837) : 146 - &
[37] FDA Written Requests: Identified Trends in Timelines and Drug Types
Barone, A.
Casey, D.
Reaman, G.
[J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S340 - S341
[38] US FDA requests hold on early clinical trials of atezolizumab
[J]. Reactions Weekly, 2017, 1671 (1) : 6 - 6
[39] FDA requests five new RCTs to evaluate LABA safety
[J]. Reactions Weekly, 2011, 1348-1349 (1) : 3 - 3
[40] Approval of novel biomarkers: FDA's perspective and major requests
Scherf, Uwe
Becker, Robert
Chan, Maria
Hojvat, Sally
[J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 : 96 - 102

← 1 2 3 4 5 →